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Summary 
Various substituted aniline derivatives were tested for genotoxicity in several short-term tests in order to 
examine the hypothesis that a Substitution at both ortho positions (2,6-disubstitution) could prevent 
genotoxicity due to steric hindrance of an enzymatic activation to electrophilic intermediates. In the 
Salmonellajmicrosome assay, 2,6-dialkylsubstituted anilines and 2,4,6-trimethylaniline (2,4,6-TMA) were 
weakly mutagenic in strain TA100 when 20% S9 mixwas used, although effects were small compared to 
those of 2,4-dimethylaniline and 2,4,5-trimethylaniline (2,4,5-TMA). In Drosophila me/anogaster, however, 
2,4,6-TMA and 2,4,6-trichloroaniline (TCA) were mutagenic in the wing spottestat 2-3 times lower doses 
than 2,4,5-TMA. In the 6-thioguanine resistance test in cultured fibroblasts, 2,4,6-TMA was again 
mutagenic at lower doses than 2,4,5-TMA. Two methylene-bis-aniline derivatives were also tested with the 
above methods: 4,4'-methylene-bis-(2-chloroaniline) (MOCA) was moderately genotoxic in al1 3 test 
systems whereas 4,4'-methylene-bis-(2-ethyl-6-methylaniline) (MMEA) showed no genotoxicity at all. 
DNA binding sturlies in rats, however, revealed that both MOCA and MMEA produced DNA adducts in 
the liver at Ievels typically found for moderately strong genotoxic carcinogens. These results indicate that 
the predictive value of the in vitro test systems and particularly the Salmonellajmicrosome assay is 
inadequate to detect genotoxicity in aromatic amines. Genotoxicity seems to be a general property of 
aniline derivatives and does not seem to be greatly influenced by substitution at both ortho positions. 
Ortho,ortho-dialkylated anilines, in general, are 
reported to be non-genotoxic (Zimmer et al., 1980; 
Mulholland et al., 1983). The hypothesis was that 
a substitution at both ortho positions could pre-
vent genotoxicity due to steric hindrance of the 
enzymatic oxidation of the aromatic amino group. 
This observation had been made earlier by various 
Correspondence; Dr. U. Friederich, Institute of Toxicology, 
Swiss Federal Institute of Technology and University of Zurich, 
Schorenstr. 16, CH-8603 Schwerzenbach (Switzerland). 
authors (Holland et al., 1974; Garner et al., 1975; 
Ashby, et al., 1982). Benzidine, for example, is 
genotoxic in most short-term tests (Ashby, 1981) 
and carcinogenic in mammals (Vesselinovitch et 
al., 1975; Nelson et al., 1982) while its analogue 
3,3',5,5'-tetramethylbenzidine was not mutagenic 
in Salmonella, in yeast, or in higher eukaryotes in 
vivo and in vitro. In mammals, the latter was not 
carcinogenic at doses 100-1000 times higher than 
benzidine (Holland et al., 1974). It was suggested 
that this Iack of genotoxicity was a result of steric 
hindrance by the 2 alkyl groups ortho to the amine 
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group, as primary aromatic amines are known to 
need enzymatic activation to the corresponding 
hydroxylamine derivatives to express genotoxic 
activity. In contradiction to this hypothesis, how-
ever, 2,4,6-trimethylaniline (2,4,6~ TMA) and 
2,4,6-trichloroaniline (2,4,6-TCA) are carcinogenic 
in mammals (Russfield et al., 1973; Weisburger et 
al., 1978). The aim of this study was therefore to 
examine more closely the genotoxic properties of 
ortho,ortho-disubstituted aniline derivatives. If such 
compounds were indeed non-genotoxic, they would 
be of great interest for replacing genotoxic aniline 
derivatives, as aniline derivatives are nowadays 
widely used chemicals. This paper describes the 
results of several anilines tested in the 
Salmonellajmicrosome assay, in the somatic mu-
tation and recombination test in Drosophila 
me/anogaster, and in the 6-thioguanine resistance 
test in rat fibroblast cultures. Furthermore, the 
DNA binding of the 2 methylenedianilines 4,4'-
methylene-bis-(2-chloroaniline) (MOCA) and 
4,4 '-methylene-bis-(2-ethyl-6-methylaniline) 
(MMEA) in rats was determined. 
Materials and methods 
Test compounds 
2,4-Dimethylaniline and 2,6-dimethylaniline 
were from Fluka, Buchs (Switzerland). 2-Ethyl-6-
methylaniline, 2,6-diethylaniline, 2-methyl-6-iso-
propylaniline, 2,6-diisopropylaniline, MMEA and 
MOCA were from Lonza AG, Basel (Switzerland). 
2,4,5-Trimethylaniline (2,4,5-TMA) was from K + 
K Labs, Plainview, NY (U.S.A.), 2,4,6-TMA and 
2,4,6-TCA were from EGA Chemie, Stammheim 
(F.R.G.). The purity of all compounds was checked 
by gas chromatography, and was in all cases 
> 99%. [Methylene.l4 C]MOCA, with a specific 
activity of 216 ,uCi/mg, was purchased from 
Amersham (U.K.). Radiochemical purity, checked 
by thin-layer chromatography (TLC, cyclohexane 
+ diethylether, 1 + 1), was > 98%. 
[Methylene~14C]MMEA was synthesized by 
condensation of 2-ethyl-6-methylaniline (154 
l'mole) with radiolabelled paraformaldehyde (73 
l'mole) in 2 m1 xylene solution containing 2 drops 
of H 2S04 25% at 145°C for 23 h. After cooling 
the solution to 90 ° C, 3 drops of N aOH 50% were 
added to pH 7 .4, and the mixture was extracted 
twice with water to remove unreacted parafor-
maldehyde. The yield of radioactive MMEA was 
73%. Its radiochemical purity, checked by TLC 
(toluene + acetone, 3 + 1), was > 98%. 
Salmonella I microsome assays 
Salmonella typhimurium strains T A98 and 
TA100 were provided by Dr. B.N. Ames (Univer-
sity of California, Berkeley, CA, U.S.A.). The S9 
fraction (9000 X g supematant of liver homo-
genate of aroclor 1254-induced SD rats; 10-40% 
in the S9 mix) was prepared according to Ames et 
al. (1975). The liver S9 fraction of aroclor-induced 
or non-induced Syrian hamsters was kindly sup-
plied by Dr. S. Albertini, Hoffmann-LaRoche AG, 
Basel (Switzerland). The solvent for all test com-
pounds was dirnethyl sulfoxide (DMSO, 50 
1!1/plate). Tests were performed without prein-
cubation following the methods of Ames et al. 
(1975), as pilot experiments with 2,4-dimethyl-
aniline bad shown that preincubation reduced the 
nurober of induced revertants in comparison to 
the standard plate incorporation protocol. The 
following modification was used: the ingredients 
for 3 replicate plates were mixed in the given 
order in a test tube (6.0 ml top agar, 1.5 ml S9 
mix, 0.15 ml DMSO containing the test com-
pound, and 0.3 ml bacteria); the suspension was 
vigorously shaken and 3 equal parts of the mixture 
were added on each of 3 replicate plates. Com-
pounds were tested at various dose Ievels, the 
limiting factor in all cases was their solubility in 
the aqueous top agar. The presence of a back-
ground lawn of bacteria on 'the minimal medium 
plates was taken as an indicator of no gross toxic 
effects. Plates were used in triplicate to determine 
the nurober of revertants. Fora comparison of the 
compounds, the relative mutagenicity was calcu-
lated: total nurober of revertants on treated plates 
divided by the number of revertants on the plates 
with solvent only. 
Somatic mutation and recombination test in Droso-
phila melanogaster 
72-h-old larvae of Drosophila melanogaster, 
trans-heterozygous for the mutations multiple wing 
hair (mwh, 3-0.0) and flare (flr, 3-38.8), were fed 
the test compounds for 48 h. Test compounds 
were dissolved in an aqueous solution containing 
3% absolute ethanol and 1% Tween 80 and used to 
prepare Drosophila Instant Medium (Formula 4-
24, Carolina Biological Supply Company, Burling-
ton, NC, U.S.A.). In order to determine the spon-
taneous mutation frequency, additionallarvae were 
simultaneously exposed to the solvent only. The 
larvae were treated, and the wings prepared and 
scored for induced spots according to Graf et al. 
(1984). Statistical analysis of the data was carried 
out as described by Frei and Würgler (1988). 
6-Thioguanine resistance test in cultured rat fibro-
blasts 
Fibroblasts were isolated from the upper inside 
of a subcutaneous air pouch (granuloma pouch 
assay, Maier, 1984), 4 days after the subcutaneous 
injection of 25 ml of germ-free air into the loose 
connective tissue between the shoulder blades 
of 230-260-g (54 ± 4 days old) male rats 
(Sprague-Dawley [lva:SIV -50.SD], lvanovas, 
Kissleg, F.R.G.) (Maier et al., 1987). Isolated cells 
were cultured in Dulbecco's minimum essential 
medium supplemented with 10% fetal calf serum 
and 0.5% gentamycin for 3 days, subsequently 
trypsinized, seeded, and exposed to the test agents 
after another 24 hin culture (pilot experiments) or 
they were exposed immediately after a 24-h cul-
ture period following isolation (subsequent experi-
ments). Exposure intervals chosen were 7 hin the 
pilot experiments and 24 h in the subsequent 
experiments. After a 24-h recovery period, cells 
were trypsinized, and subjected to a 6-day expres-
sion period. Mutant clones were recovered after a 
7-day growth period in selective 6-thioguanine 
medium as described earlier (Maier et al., 1987). 
The solvents used were acetone for the 3 chem-
ieals 2,4,5-TMA, 2,4,6-TMA and MOCA (1% in 
the medium}, and methanol for MMEA (1% in the 
medium). Significance of the results was tested by 
the method of Kastenbaum and Bowman. 
D NA binding in rat Ii ver, lung, kidney, and bladder 
Both MOCA and MMEA were dissolved in 
0.05 N HCI. In the case of MOCA, 2 application 
solutions were prepared that differed 10-fold in 
specific radioactivity, while MMEA was tested at 
only one dose Ievel. Both compounds were admin-
istered to male 210-240-g Sprague-Dawley rats 
[Iva:SIV-50.SD] (lvanovas, Kissleg, F.R.G.) by 
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oral gavage. Chemical and radioactivity doses are 
presented in Table 4. Urine was collected for 4 h. 
20 h after administration, the animals were killed 
by heart puncture under ether anesthesia, and 
liver and lung were excised. The carcasses were 
frozen at - 20 ° C. Later they were thawed to 
remove kidneys and bladder. Isolation and purifi-
cation of DNA was performed essentially accord-
ing to Sagelsdorff et al. (1983): preparation of a 
chromatinpellet by precipitation with a detergent, 
then homogenizing in lysing medium, deproteinat-
ing with phenoljchloroformjisoamyl alcohol, and 
extraction with ether. DNA was then purified by 
adsorption on a hydroxylapatite column, dialysed, 
and precipitated with ethanol. After dissolving 
pure DNA in buffer, the concentration was 
determined spectrophotometrically, the radioactiv-
ity of an aliquot was measured by scintillation 
counting, and the specific radioactivity calculated. 
If the DNA was radiolabelled, another purifica-
tion round was performed involving deproteina-
tion, ether extraction, dialysis, precipitation with 
ethanol, and dissolving in buffer, to again de-
termine the specific activity. Those DNA samples 
which contained more than a total of 50 cpm were 
subjected to nucleotide analysis according to 
Sagelsdorff et al. (1988). DNA was enzymatically 
hydrolyzed to the 3' -deoxynucleotides which were 
separated by high-performance liquid chromatog-
raphy (HPLC). This made it possible to dis-
tinguish between radioactivity coeluting with the 
natural DNA constituents (i.e., radioactivity which 
bad been biosynthetically incorporated into the 
nucleotides) and radioactivity eluting apart from 
natural DNA constituents (indicating covalently 
bound test compound). 
In order to determine the possible contribution 
of radiolabelled protein to the radioactivity on the 
DNA (protein contamination can amount to 0.2% 
in DNA with the described DNA isolation method, 
as shown by Caviezel et al., 1984), radioactivity 
bound to protein was determined. This involved 
repeated precipitation of chromatin protein (from 
the phenoljchloroformjisoamyl alcohol extract) 
with acetone and dissolving in a detergent to 
constant radioactivity (Sagelsdorff et al., 1983). 
The specific activity was determ.ined by scintilla-
tion counting of an aliquot after determination of 
the protein concentration by the Lowry. method. 
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DNA was isolated from a control rat which did 
not receive radioactivity in order to show that no 
radioactive contamination occurred during DNA 
isolation. The specific DNA activity attributable 
to covalent nucleotide-test compound adducts was 
expressed per administered dose and converted to 
the molar units of the 'covalent binding index' 
(CBI) (Lutz, 1979) as 1-'mole chemical bound per 
mole DNA nucleotidejmmole chemical adminis-
tered per kg body weight. 
Results 
Salmonella I microsome assays 
Experiments with 2,6-dimethylaniline in TA100 
showed an increasing mutagenicity when the 
amoun:t of rat liver homogenatein the S9'mix was 
elevated from 10% to 20%. Therefore, all tests 
were carried out with 20% S9 mix. 2,6-Dimethyl-
aniline, 2-ethyl-6-methylaniline, 2,6-diethylaniline, 
and 2-isopropyl-6-methylaniline were all weakly 
mutagenic in strain TA100. The small dose-related 
increase in the relative mutagenicity was in all 
cases below a factor of 2. With increasing chain 
length from ethyl to isopropyl a decrease in muta-
genicity can be noted; 2,6-diisopropyl aniline was 
no Ionger mutagenic. Results are presented in 
Table 1. None of these compounds showed muta-
genicity in strain T A98. Results with trisubstituted 
anilines are presented in Fig. 1a. 2,4,6-TMA gave 
significant dose-related mutagenic effects in TAlOO 
which were, however, very weak compared to those 
of 2,4,5-TMA. Of the dianilines MMEA failed to 
TABLE 1 
give a positive result in TA98 or TAIOO although 
various amounts of rat or Syrian hamster liver 
homogenate were used in the S9 mix, whereas the 
simultaneously tested MOCA was positive in all 
experiments (Fig. lb). Activation of MOCA by 
hamster instead of rat liver homogenate increased 
the mutagenicity. 
Somatic mutation and recombination test in 
Drosophila me/anogaster 
Three trisubstituted anilines (2,4,5- and 2,4,6-
TMA and 2,4,6-TCA) as well as MOCA and 
MMEA, but not disubstituted derivatives, were 
investigated for genotoxicity in Drosophila. The 
trimethylanilines were both tested at 3 different 
concentrations. The results of all tested com-
pounds are presented in Table 2. As 2,4,6·TMA 
was 2-3 tim es more toxic than 2,4,5-TMA for the 
larvae, it had to be tested at lower doses. Both 
compounds were positive for small single spots; 
large single and twin spots were not significantly 
different from controls. At 4 mM, 2,4,6-TMA 
showed a comparable genotoxicity to 2,4,5-TMA 
at 15 mM while 2,4,6-TCA at 5 mM was slightly 
more genotoxic than 2,4,6-TMA. MOCA and 
MMEA were both tested at 5 mM as higher doses 
wereinsoluble in the solvent. MOCA was weakly 
positive for small single spots but negative for 
large single spots and twin spots (Fig. 2a). MMEA 
was negative for all spot sizes at 5 mM (Fig. 2b). 
As the twin spots were not different from controls, 
the figures show only the results of the single 
spots. 
MUTAGENICITY OF 2,6-DISUBSTITUTED ANILINES IN Salmonella typhimurium TA100 AFTER METABOLIC ACTIVA· 
TION WITH 20% RAT LIVER HOMOGENATE IN THE S9 MIX 
To allow comparison, the results are presented as relative mutagenicity (total revertants of triplicate plates divided by spontaneous 
revertants). nd, no data. t, toxic for bacteria. 
Dose Relative mutagenicity 
(p.molejplate) Dimethyl· Methylethyl· Diethyl- Methylisopropyl- Diisopropyl-
aniline aniline aniline aniline aniline 
4.1 1.21 1.02 1.30 1.15 0.97 
8.3 1.26 1.23 1.32 1.12 0.95 
12.4 1.36 .nd 1.32 1.10 
16.5 1.39 1.51 
24.6 1.48 1.52 
33.1 1.43 
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Fig. 1. (a) Mutagenicity of 2,4,5- and 2,4,6-trimethylaniline (TMA) in Salmonella typhimurium TA98 and TAlOO after metabolic 
activation with 20% rat liver homogenate in the S9 mix. Total nurober of revertants per plate as mean of triplicates. •--• 
2,4,5-TMA in TAlOO, o---- -o 2,4,6-TMA in TAlOO, ·---- -II 2,4,5-TMA in TA98, D---- -o 2,4,6-TMA in TA98. (b) 
Mutagenicity of MOCA and MMEA in Salmonella typhimurium TA98 and TAlOO after metabolic activation with 20% rat liver 
homogenate in the S9 mix. Total number of revertants per plate as mean of triplicates. •--• MOCA in TAIOO, o--- - -o 
MMEA in TAlOO, II---- _. MOCA in TA98, D---- -0 MMEA in TA98. 
6-Thioguanine resistance test in rat fibroblast cu/-
tures 
Pilot experiments showed that freshly isolated 
(as opposed to subcultured) fibroblasts, incubated 
at 19% 0 2 (as opposed to 5% 0 2 ), were most 
sensitive for testing aniline derivatives. Treatment 
of the cells with the test compound for 24 rather 
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spot size 
than 7 h further increased the nurober of mutants. 
Experiments were carried out in a dose range of 
74-740 p.mole test compound per m1 medium for 
2,4,5-TMA, and of 37-148 p.molejml for 2,4,6-
TMA, as 2,4,6 .. TMA was rather toxic for the cells. 
2,4,6-TMA showed the maximum rate of mutants 
at 74 p.mole/ml whereas for 2,4,5-TMA the maxi-
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Fig. 2. Single wing spots induced by 48 h treatment of 72-h-old trans-heterozygous larvae of Drosophila melanogaster with 5 mM 
MOCA (a) and S mM MMEA (b). Open bars: controls (442 wings); hatched bars: treated series (200 wings). 
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TABLE 2 
WING SPOTS INDUCED BY 48-h TREATMENT OF 72-h-old TRANS-HETEROZYGOUS LARVAE OF Drosophila me/anogas-
ter 
Compound Number Spots per wing and statistical diagnoses a 
concentration of wings 
small large twin total 
single single spots spots 
spots spots m=5.0 m=2.0 
m=2.0 m=S.O 
Control 442 0.22 0.05 0.01 0.28 
2,4,5-TMA 
10mM 136 0.33+ 0.06- 0.01 i 0.40+ 
15mM 160 0.41+ 0.08- 0.03 i 0.52+ 
20mM 184 0.57+ 0.07- 0.03 i 0.66+ 
2,4,6-TMA 
2mM 90 0.21- 0.08- 0.01 i 0.30-
4mM 120 0.37+ 0.10 w 0.01 i 0.47+ 
6mM 160 0.37+ 0.09- 0.03 i 0.48+ 
2,4,6-TCA 
5mM 80 0.45+ 0.08- 0.01 i 0.54+ 
MOCA 
5mM 200 0.34+ 0.06- 0.01- 0.42w 
MMEA 
5mM 240 0.21- 0.05- 0.00- 0.26-
a Statistical diagnoses according to Frei and Würgler (1988). +, positive; -, negative; w, weak; i, inconclusive. Probabilitylevels 
a = fJ = 0.05. One-sided statistical tests. Small single spots, 1-2 cells; large single spots, > 2 cells. m, multiplication factor. 
mum rate was at 148 p.molejml. No dose response 
was obtained, which is considered to be due mainly 
to a toxic or growth:--inhibiting activity of the 
chemicals. Results are summarized in Table 3. 
Treating freshly isolated fibroblasts with 35-364 
nmole MMEA per ml medium resulted in no 
mutant clones in 2 independent experiments. 
MOCA tested in the same dose range induced 2 
mutants per 106 cells at 36 nmolejml medium 
(not significantly different from control) and 4 
mutants per 106 cells at 72 nmolejml medium. In 
a second identical test no clones could be de-
tected. 
DNA binding of MOCA and MMEA 
The amount of radioactivity excreted in the 
urine during 4 h following oral application was 
17% in the MOCA high-dosed rats, 10% in the 
MOCA low-dosed rats, and 8% in th~ rats treated 
with MMEA. When the rats were killed after 20 h, 
2% of the administered radioactivity was found in 
the liver, 0.13-0.19% in the blood, 0.10-0.15% in 
the kidneys, and less than 0.01% in the bladder. In 
the lung, a marked difference was noted between 
the MOCA- and the MMEA-treated animals: 
0.03-0.09% of Iabelied 'MOCA (or metabolites) 
was found versus 0.016% of Iabelied MMEA (or 
metabolites). The results with MOCA agree with 
those found by Farmer et al. (1981) and Tobes et 
al. (1983). 
From the first to the second DNA purification 
the specific activity was either constant or not 
significantly decreased, so that a third purification 
round was not necessary. In order to distinguish 
between biosynthetic incorporation of radioactive 
fragments into the DNA and genuine covalent 
binding, DNA was enzymatically degraded to the 
nucleotides which were separated by HPLC. The 
specific radioactivity of the MOCA liver and lung 
DNA and MMEA liver DNA was sufficiently 
high (52-320 dpmjmg) to allow for this analysis. 
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TADLE 3 
6-THIOGUANINE RESIST ANCE TEST 
lnduction of mutations after 24 hin vitro exposure of fibroblasts to 2,4,5- and 2,4,6-trimethylaniline (TMA), and 4,4'-methylene-bis-
(2-chloroaniline) (MOCA), and 4,4' -methylene-bis-(2-ethyl-6-methylaniline) (MMEA). nd, no data. -. no clones detected, resulting in 
a mutant frequency below 1.1-4.4 (depending on the number of cells tested). 
Compound Cloning efficiency Clone forming cells Mutant frequency 
concentration (%) tested·10 5 (mean·10- 6 ) 
(}'g/ml medium) expt. 1 expt. 2 expt. 1 expt. 2 expt. 1 expt. 2 
2,4,5-TMA 
74 75 nd 9.00 nd nd 
148 74 52 8.88 6.24 11.3 8.0 
370 64 46 5.12 5.52 3.9 1.88 
740 63 nd 4.41 nd nd 
2,4,6-TMA 
37 69 60 8.28 7.20 1.28 1.4 a 
74 62 51 7.44 6.12 6.7 4.9 
148 64 56 7.68 6.72 2.6 
Control 91 72 9.10 8.64 1.2 
MOCA 
36 56 50 5.04 6.00 2.0 8 
72 47 41 3.76 4.92 4.0 
181 39 40 3.12 4.80 
362 41 36 4.10 4.32 
MMEA 
36 59 52 4.72 6.24 
72 51 46 4.08 5.52 
177 49 45 4.41 5.40 
364 38 40 2.28 4.80 
Control 63 80 7.56 8.80 1.5 
a Not significantly different from control (method of Kastenbaum and Bowman, probability Ievels a = ß = 0.05, one--sided statistical 
tests). 
In all 3 samples, 2 peaks of radioactivity eluted 
after the natural nucleotides, at retention times 
normally seen with lipophilic nucleotide-carcino-
gen adducts. These putative adducts all bad differ-
ent retention times and were therefore probably 
all structurally unique. In the liver andin the lung 
of the MOCA-treated animals 75% and 87% of the 
radioactivity, respectively, was covalently bound 
to DNA, and in the liver of the MMEA-treated 
animals 98% of the radioactivity was covalently 
bound. In order to compare the DNA binding 
ability of MOCA and MMEA with other sub-
stances, CBI values were calculated. The values 
ranged from 17 to 35 in liver, 1.4 to 72 in lung, 4 
in kidney, and were below the Iimit of detection in 
the bladder (Table 4). There was a marked dif-
ference between MOCA and MMEA only in bi-
nding to lung DNA: MOCA produced 30-50 
times niore adducts than did MMEA. In the other 
argans the effects of the compounds were com-
parable. With both test compounds, the radioac-
tivity of bladder DNA was not significantly differ-
ent from control values. Because of the small 
amount of bladder DNA, the detection limitwas 
at a CBI value of 4. 
The specific activity of chromatin protein iso-
lated from the lung was at about the same level as 
for DNA with both MOCA and MMEA. In liver, 
kidney, and bladder protein had a 5-l 0 times 
higher specific activity. As the maximum possible 
contamination of the DNA preparations with pro-
teinwas less than 0.2% (Caviezel et al., 1984), this 
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TABLE4 
COVALENT BINDING OF [METHYLENE-14 C]LABELLED 4,4'-METHYLENE-BIS-{2-CHLOROANILINE) (MOCA) AND 
4,4'-METHYLENE-BIS-(2-ETHYL-6-METHYLANILINE) (MMEA) TO DNA IN MALE SPRAGUE-DAWLEY RATS, 20 h 
FOLLOWING ORAL GA VAGE 
Test compound MOCA MMEA 
Dose Ievel Low High High 
Chemical dose 
(mgjkg) 1.43 2.32 28.1 29.6 31.6 29.3 
Radioactivity 
(108 dpmjkg) 6.13 11.9 14.5 15.3 16.8 15.5 
DNA binding potency (CBI values) 
Li ver 20 b 17 b 33 8 23 b 34 8 35 b 
Lung 71 b 72b 41 8 34 b ~1.4 c ~ 1.8 c 
Kidney nd ~4c nd ~4c nd ~4c 
Bladder < 4 d < 4 d <4d 
nd, no data. 
8 On the basis of nucleotide analyses. 
b Percent adduct formation taken from nucleotide analysis a. 
c No nucleotide analysis possible; upper Iimit value derived from specific activity of DNA. 
d DNA of 2 animals pooled. Specific activity of DNA below Iimit of detection. 
The covalent binding index (CBI) is defined as: 
CBI = J.Lmole chernical boundjmole DNA nucleotide 
mrnole chemical applied/kg body weight 
CBI = dpmjmg DN~ x3.09X10 8 
dpmjkg body we1ght 
contribution to the DNA radioactivity can be 
ignored. 
Discussion 
Salmon~lla / microsome assays 
Tests with 2,6-disubstituted compounds 
showed, in cantrast to reports in the literature, 
weak mutagenicity when 20% instead of 10% rat 
liver homogenate was used as the activation sys-
tem. The relative mutagenicity varied between 1.10 
and 1.52. These weak effects are interpreted as 
positive because (1) they were reproducible, (2) 
the increase could be observed with at least 3 
different doses, and (3) at least for 2,6-dirnethyl-
aniline and 2-methyl-6-ethylaniline there was a 
certain dose-effect relationship (weak increase of 
the relative mutagenicity with increasing dose). 
Increase of the length of the side chain in the 
ortho positions resulted in decreased mutagenicity 
(2,6-düsopropylaniline was negative at the tested 
doses ). The same effect has been seen in a series of 
phenylenediamines with alkyl or alkoxy sub-
stituents (Shahin et al., 1983). 2,6-Dialkylanilines 
with Ionger side chains showed increased bacteri-
cidal effects tagether with a decreased mutagenic-
ity. 
Somatic mutation and recombination test in 
Drosophila melanogaster 
In Drosophila the test compounds tended to 
induce mainly small spots, which suggests that the 
somatic mutations were induced late in the devel-
opment of the larvae, at a time point where only 
1-2 more cell divisions took place. This phenome-
non can be explained by the increasing activity of 
the metabolizing enzymes in the course of the 
development of the larvae (Hällström et al., 1983). 
From the absence of induced twin spots it can be 
concluded that the compounds do not exhibit 
strong recombinogenic activity. When MOCA and 
MMEA were tested, problems arose because of 
their low solubility in the aqueous solvent. The 
maximum possible concentration was 5 mM. 
MOCA was weakly positive at this dose level 
whereas MMEA was negative. 
6-Thioguanine resistance test in rat fibroblast cul-
tures 
The experiments with fibroblasts in culture 
showed the importance of adequate activation of 
the aniline derivatives to reactive metabolites. 
Modifications which could improve oxidative 
activation increased the sensitivity of the test: 
freshly isolated fibroblasts usually have a higher 
enzyme activity than subcultured ones, exposure 
of the fibroblasts to the test compounds for 24 
rather than 7 h allow a more complete metaboliza-
tion, and incubation at 21% instead of 5% 0 2 
provides more oxygen for oxidative metabolism. It 
can be concluded that the activation mechanism 
in mammalian cells for anilines is not stable under 
in vitro conditions. Therefore handling of the 
freshly isolated cells, culture conditions, and cul-
ture time will affect the activation of anilines. This 
might explain why the positive results of MOCA 
could not be reproduced in a second experiment. 
The decrease of mutagenicity at high dose Ievels in 
the thioguanine test can be explained by the possi-
ble interference of anilines with prostaglandin 
synthesis which in turn affects DNA synthesis and 
mutation fixation (Maier and Schawalder, 1988). 
DNA binding in the rat 
The DNA binding experiments in rats showed 
comparable CBI values for MOCA and MMEA in 
the liver. The differences of the liver CBI between 
the 2 dose groups of MOCA was in the range of 
animal-to-animal variations. A liver CBI of 20-30, 
as was also reported by Silk and Martin (1986) for 
MOCA, is typically found for weak to moderately 
strong carcinogens. Using the linear correlation 
shown by Lutz (1986) between CBI and tumori-
genic potency in vivo (TD50 , Gold et al., 1984), 
this CBI Ievel would correspond 'to a TD50 of 
about 0.2 mmolejkg body weightjday, which cor-
relates well with carcinogenicity data for MOCA 
(10 mgjkgjday to induce a 50% liver tumor inci-
dence in CD rats; Gold et al., 1984). In the lung 
there was a significant difference in DNA binding 
between MOCA and MMEA: MOCA was 30-50 
times strenger than MMEA. This suggests that 
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MMEA (which has not been tested for carcinogen-
icity) might be less likely than MOCA to cause 
lung tumors. In MOCA, lung DNA bindingwas 
higher than that of liver, in agreement with: the 
finding that MOCA effectively induces ·lung 
tumors (Kommineni et al., 1978). These· authors 
judged the lung tobe the mostsensitive organ for 
tumor formation by MOCA. The activation of 
MOCA to DNA reactive metabolites probably 
tak:es place in the lung and is saturable in . this 
tissue, as the CBI is markedly lower in the lung at 
the high dose level. The DNA binding in kidney 
and bladder was very low or not detectable for 
both MOCA and MMEA so that significant tumor 
Ionnation in these organs appears unlikely. 
Structure-activity relationships 
The hypothesis that aniline derivatives could be 
rendered innocuous by substituting both ortho 
positions was not confirrned by this work. Eight 
out of 9 investigated compounds tested were 
genotoxic in one or more systems. In addition, 
recent data from the National Toxicology Pro-
gram showed that 2,6-dimethylaniline induced 
tumors in rats at about the same dose Ievel as does 
2,4,5-TMA. This is in strong centrast to the data 
with Salmonella, where 2,6-dimethylaniline was 
about 20 times less mutagenic than 2,4,5-TMA. 
The above quantitative differences between the 
Salmonellajmicrosome · assay and the other tests 
used in the present sturlies are illustrated even 
better with 2,4,5-TMA and 2,4,6-TMA. 2,4,6-TMA 
was about 20 times less · mutagenic than 2,4,5-
TMA, although it was 5-10 times more potent in 
evoking tumors. It seems, therefore, that the 
Salrnonellajmicrosome assay underestimates the 
genotoxicity of di-ortho-substituted compounds in 
mammals. The data obtained with Drosophila and 
fibroblasts in culture, on the other band, agree 
with the potency ranking seen in the carcinogenic-
ity bioassay in rodents. The similarity of the re-
sults of tests using Drosophila and fibroblasts. in 
culture bad not been expected, because in the 
latter the compounds are probably activated via 
prostagtandin synthase pathways (Maier, 1984), 
while in Drosophila the activation depends mainly 
on cytochrome P-450 (Baars et al., 1977). While 
the Drosophila data with 2,4,5- and 2,4,6-TMA 
seem to correlate with tumorigenic potency in a 
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quantitative manner, this test system ranked 2,4,6· 
TCA about equally with 2,4,6-T MA. The carcino· 
genicity bioassay data, however, showed that 
2,4,6· TCA was about 5 times less potent than the 
methyl analogue. These results indicate that one 
must be careful in attempting quantitative ex-
trapolations. 
MMEA was an even moreextreme case: MMEA 
was negative not only in the Salmonellajmicro-
some assay, but also in the somatic mutaiion and 
recombination test in Drosophila and in the 6-
thioguanine resistance test in rat fibroblast cul-
tures. However, it produced covalent binding to 
rat liver DNA at about the same Ievel as the 
proven carcinogen MOCA. 
A Iiterature survey (Kugler-Steigmeier, 1988, 
available upon request) showed that di· and tri-
substituted aniline derivatives with one free ortho 
position are generally mutagenic and carcinogenic. 
Negative results in the Salmonellajmicrosome as· 
say were found for monosubstitutedas well as for 
2,6-di- and 2,4,6-tri-substituted compounds. In the 
case of the monosubstituted anilines, the results 
were somewhat confusing, as a few authors re-
ported a weak mutagenicity in substances that 
were classified as negative by others. Therefore, 
several conclusions published in the past appear 
to be unreliable. 
In considering the present experiments as weil 
as the reports in the literature, one must conclude 
that no class of aniline derivatives can be consid-
ered non-genotoxic. A quantitative prediction was 
poor with the Salmonella/microsome assay, more 
satisfactory with Drosophila and rat fibroblasts in 
vitro. A DNA binding study in an intact mam-
malian organism probably reflects the complicated 
enzymatic activation and inactivation processes 
most closely (Lutz, 1986). Since genotoxicity ap-
pears to be a general characteristic of aniline 
derivatives, and hence quantitative data are needed 
for risk assessment, such quantitative in vivo cova-
lent binding studies might therefore be preferred 
over qualitative results from other short-term tests. 
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